Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

15.0%

3 terminated/withdrawn out of 20 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

35%

7 trials in Phase 3/4

Results Transparency

93%

14 of 15 completed trials have results

Key Signals

1 recruiting14 with results

Enrollment Performance

Analytics

Phase 2
8(40.0%)
Phase 3
6(30.0%)
Phase 1
4(20.0%)
Phase 4
1(5.0%)
N/A
1(5.0%)
20Total
Phase 2(8)
Phase 3(6)
Phase 1(4)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT02882191Phase 2Completed

Evaluation of the Efficacy and Safety of LevoCept

Role: collaborator

NCT05534620Phase 1Recruiting

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Role: collaborator

NCT03785366Phase 3Completed

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

Role: collaborator

NCT03927703Phase 3Completed

A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC

Role: collaborator

NCT04535531Phase 3Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study

Role: collaborator

NCT03927716Phase 3Completed

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Role: collaborator

NCT04465916Phase 2Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Role: collaborator

NCT03283462Not ApplicableCompleted

Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)

Role: collaborator

NCT04013334Phase 2Unknown

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Role: collaborator

NCT03847389Phase 1Terminated

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Role: collaborator

NCT01746095Phase 2Completed

Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Role: collaborator

NCT01817582Phase 2Completed

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Role: collaborator

NCT00823862Phase 1Completed

Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

Role: collaborator

NCT00486291Phase 2Completed

Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

Role: collaborator

NCT00737633Phase 2Terminated

Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults

Role: collaborator

NCT00600067Phase 2Completed

A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

Role: collaborator

NCT00432562Phase 1Completed

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

Role: collaborator

NCT01016834Phase 4Completed

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

Role: collaborator

NCT00752258Phase 3Completed

A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows

Role: collaborator

NCT00752050Phase 3Completed

Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows

Role: collaborator

All 20 trials loaded